12:00 AM
 | 
Nov 04, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

InterMune Inc.

(ITMN), Brisbane, Calif.

Business: Pulmonary, Infectious diseases, Cancer

Leerink Swann analyst Navdeep Jaikaria raised his price target to $59 from...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >